About Servier
Servier is a global pharmaceutical company focused on the research, development, manufacture and marketing of medicinal products in the areas of cardiovascular and chronic venous diseases, neuropsychiatric disorders, oncology and diabetes. We are number two in Europe and number eight worldwide in cardiology, with the largest product range addressing the needs of all patient profiles. To learn more about the Servier Group, please visit our corporate site.
60 Years of Embedded Experience
In 1954, Jacques Servier took over a pharmaceutical production company with nine employees in Orléans, France. Today it is France’s leading independent pharmaceutical company and the second-largest French pharmaceutical company, with 22,000 employees in 66 countries. Jacques Servier was dedicated to research and this legacy remains, with 25% of revenue and 2,900 employees dedicated to R&D.
Inauguration of the Research Center in Saclay scheduled
First bioproduction batches in Gidy scheduled
Servier offers contract development and manufacturing services across its global network
Launch of Lonsurf in several European countries
Death of the founding president
Olivier Laureau becomes President of the Servier International Research Foundation and of the Servier Group
Servier is awarded the Galien Prize in recognition of its creativity in research
Creation of Biogaran
The first external growth operation with the acquisition of a 51% shareholding in the Hungarian company Egis Pharmaceutical
The first production site outside France is built at Arklow, Ireland
The journal Scrip calls Servier ‘the world’s most creative pharmaceutical company’
The Gidy ‘factory village’ is built in the Loiret, and becomes Servier’s social showcase
International development begins with the opening of the first subsidiary in London
The Servier Research Centre opens in Suresnes
Jacques Servier creates a pharmaceutical company in Orléans. A year later, the company launches its first two drugs (an antihypertensive and an antidiabetic)